Trial intelligence / Profile preview

Closed-loop vs Open-loop Propofol and Remifentanil System

NCT02492282Phase 3Completed

Sponsor
Universidad de Antioquia
Start
Jun 2015
Primary completion
Dec 2015
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 3, randomised, single-blind trial of propofol and remifentanil in general anesthesia, sponsored by Universidad de Antioquia. Primary endpoint: Time in adequate anesthetic depth. Started Jun 2015; status: completed.

02

Drugs

propofolremifentanil
03

Conditions

general anesthesia

Beyond the preview

Go deeper on NCT02492282.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02492282.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call